HEADER HYDROLASE 13-JUL-17 5XZR TITLE THE ATOMIC STRUCTURE OF SHP2 E76A MUTANT IN COMPLEX WITH ALLOSTERIC TITLE 2 INHIBITOR 9B COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 11; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1-534; COMPND 5 SYNONYM: PROTEIN-TYROSINE PHOSPHATASE 1D,PTP-1D,PROTEIN-TYROSINE COMPND 6 PHOSPHATASE 2C,PTP-2C,SH-PTP2,SHP2,SH-PTP3; COMPND 7 EC: 3.1.3.48; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTPN11, PTP2C, SHPTP2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS PHOSPHATASE, SH2 DOMAIN, ALLOSTERIC INHIBITOR, CANCER, SIGNALING KEYWDS 2 PROTEIN, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR D.LI,J.XIE,J.ZHU,C.LIU REVDAT 3 22-NOV-23 5XZR 1 REMARK REVDAT 2 17-JAN-18 5XZR 1 JRNL REVDAT 1 13-DEC-17 5XZR 0 JRNL AUTH J.XIE,X.SI,S.GU,M.WANG,J.SHEN,H.LI,J.SHEN,D.LI,Y.FANG,C.LIU, JRNL AUTH 2 J.ZHU JRNL TITL ALLOSTERIC INHIBITORS OF SHP2 WITH THERAPEUTIC POTENTIAL FOR JRNL TITL 2 CANCER TREATMENT. JRNL REF J. MED. CHEM. V. 60 10205 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 29155585 JRNL DOI 10.1021/ACS.JMEDCHEM.7B01520 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_2650 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.86 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 13123 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.242 REMARK 3 R VALUE (WORKING SET) : 0.240 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 657 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.8631 - 4.7703 1.00 2639 139 0.2055 0.2191 REMARK 3 2 4.7703 - 3.7950 1.00 2491 132 0.2071 0.2836 REMARK 3 3 3.7950 - 3.3178 1.00 2457 129 0.2770 0.3229 REMARK 3 4 3.3178 - 3.0156 1.00 2445 128 0.2959 0.3455 REMARK 3 5 3.0156 - 2.8001 1.00 2434 129 0.3151 0.3257 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.330 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.710 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 61.17 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 4210 REMARK 3 ANGLE : 0.659 5702 REMARK 3 CHIRALITY : 0.045 615 REMARK 3 PLANARITY : 0.003 747 REMARK 3 DIHEDRAL : 15.208 2504 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): -23.1628 81.5595 29.0132 REMARK 3 T TENSOR REMARK 3 T11: 0.2989 T22: 0.3776 REMARK 3 T33: 0.3904 T12: 0.0112 REMARK 3 T13: -0.0427 T23: -0.0074 REMARK 3 L TENSOR REMARK 3 L11: 1.0035 L22: 0.7224 REMARK 3 L33: 2.5260 L12: -0.2267 REMARK 3 L13: -0.9661 L23: 0.1559 REMARK 3 S TENSOR REMARK 3 S11: 0.0212 S12: 0.0990 S13: -0.0621 REMARK 3 S21: -0.1954 S22: -0.1013 S23: 0.0241 REMARK 3 S31: -0.0159 S32: 0.2817 S33: -0.0025 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5XZR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 14-JUL-17. REMARK 100 THE DEPOSITION ID IS D_1300004426. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-SEP-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97853 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24013 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 19.863 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.452 REMARK 200 R MERGE (I) : 0.17000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.2700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.87 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.39 REMARK 200 R MERGE FOR SHELL (I) : 0.58200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.630 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2SHP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM FORMATE, 0.1 M BICINE PH REMARK 280 8.5, 15% W/V PEG 5000MME, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.87500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 109.59500 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.87500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 109.59500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -22 REMARK 465 GLY A -21 REMARK 465 SER A -20 REMARK 465 SER A -19 REMARK 465 HIS A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 SER A -12 REMARK 465 SER A -11 REMARK 465 GLY A -10 REMARK 465 LEU A -9 REMARK 465 VAL A -8 REMARK 465 PRO A -7 REMARK 465 ARG A -6 REMARK 465 GLY A -5 REMARK 465 SER A -4 REMARK 465 HIS A -3 REMARK 465 MET A -2 REMARK 465 ALA A -1 REMARK 465 SER A 0 REMARK 465 THR A 239 REMARK 465 THR A 240 REMARK 465 ASP A 241 REMARK 465 GLU A 313 REMARK 465 PHE A 314 REMARK 465 GLU A 315 REMARK 465 THR A 316 REMARK 465 LYS A 317 REMARK 465 CYS A 318 REMARK 465 ASN A 319 REMARK 465 ASN A 320 REMARK 465 SER A 321 REMARK 465 LYS A 322 REMARK 465 PRO A 323 REMARK 465 LYS A 324 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 3 OG REMARK 470 VAL A 14 CG1 CG2 REMARK 470 LYS A 55 CG CD CE NZ REMARK 470 LYS A 89 CG CD CE NZ REMARK 470 LYS A 91 CG CD CE NZ REMARK 470 LYS A 120 CG CD CE NZ REMARK 470 GLU A 123 CG CD OE1 OE2 REMARK 470 ASP A 156 CG OD1 OD2 REMARK 470 LYS A 157 CG CD CE NZ REMARK 470 ASP A 162 CG OD1 OD2 REMARK 470 LYS A 164 CG CD CE NZ REMARK 470 LYS A 199 CG CD CE NZ REMARK 470 THR A 205 OG1 CG2 REMARK 470 LYS A 235 CG CD CE NZ REMARK 470 LEU A 236 CG CD1 CD2 REMARK 470 GLU A 238 CG CD OE1 OE2 REMARK 470 LYS A 242 CG CD CE NZ REMARK 470 VAL A 243 CG1 CG2 REMARK 470 LYS A 244 CG CD CE NZ REMARK 470 LYS A 274 CG CD CE NZ REMARK 470 GLU A 299 CG CD OE1 OE2 REMARK 470 VAL A 301 CG1 CG2 REMARK 470 LYS A 364 CG CD CE NZ REMARK 470 LYS A 482 CG CD CE NZ REMARK 470 ARG A 527 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 528 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 532 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASN A 92 N - CA - C ANGL. DEV. = 19.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 48 81.04 56.01 REMARK 500 LYS A 91 77.13 55.63 REMARK 500 ASN A 92 -18.88 4.39 REMARK 500 LYS A 129 34.92 -99.18 REMARK 500 SER A 142 -73.69 -64.76 REMARK 500 ASP A 155 1.57 -63.89 REMARK 500 ASP A 156 113.07 67.04 REMARK 500 LYS A 157 -42.80 74.99 REMARK 500 SER A 160 146.11 65.85 REMARK 500 ASN A 161 178.88 62.97 REMARK 500 LEU A 177 -33.23 72.65 REMARK 500 VAL A 181 38.39 -97.36 REMARK 500 LYS A 213 -81.84 -67.40 REMARK 500 PRO A 215 -174.00 -67.98 REMARK 500 LEU A 216 -157.03 -77.15 REMARK 500 ASN A 217 85.24 -154.92 REMARK 500 ALA A 237 58.58 -165.39 REMARK 500 VAL A 243 147.68 -174.01 REMARK 500 LYS A 244 -144.89 -160.53 REMARK 500 VAL A 301 -73.29 66.59 REMARK 500 SER A 302 144.80 66.94 REMARK 500 TYR A 380 68.43 -113.79 REMARK 500 ALA A 392 78.01 -115.25 REMARK 500 ASP A 395 -22.46 89.96 REMARK 500 CYS A 459 -125.45 -150.78 REMARK 500 SER A 460 -87.31 -79.51 REMARK 500 ILE A 463 -35.35 -131.36 REMARK 500 GLU A 481 -74.64 -86.58 REMARK 500 VAL A 505 101.60 61.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8J6 A 601 REMARK 999 REMARK 999 SEQUENCE REMARK 999 SEQUENCE OF THE PROTEIN WAS BASED ON ISOFORM 2 OF DATABASE Q06124 REMARK 999 (PTN11_HUMAN) DBREF 5XZR A 1 534 UNP Q06124 PTN11_HUMAN 1 534 SEQADV 5XZR MET A -22 UNP Q06124 EXPRESSION TAG SEQADV 5XZR GLY A -21 UNP Q06124 EXPRESSION TAG SEQADV 5XZR SER A -20 UNP Q06124 EXPRESSION TAG SEQADV 5XZR SER A -19 UNP Q06124 EXPRESSION TAG SEQADV 5XZR HIS A -18 UNP Q06124 EXPRESSION TAG SEQADV 5XZR HIS A -17 UNP Q06124 EXPRESSION TAG SEQADV 5XZR HIS A -16 UNP Q06124 EXPRESSION TAG SEQADV 5XZR HIS A -15 UNP Q06124 EXPRESSION TAG SEQADV 5XZR HIS A -14 UNP Q06124 EXPRESSION TAG SEQADV 5XZR HIS A -13 UNP Q06124 EXPRESSION TAG SEQADV 5XZR SER A -12 UNP Q06124 EXPRESSION TAG SEQADV 5XZR SER A -11 UNP Q06124 EXPRESSION TAG SEQADV 5XZR GLY A -10 UNP Q06124 EXPRESSION TAG SEQADV 5XZR LEU A -9 UNP Q06124 EXPRESSION TAG SEQADV 5XZR VAL A -8 UNP Q06124 EXPRESSION TAG SEQADV 5XZR PRO A -7 UNP Q06124 EXPRESSION TAG SEQADV 5XZR ARG A -6 UNP Q06124 EXPRESSION TAG SEQADV 5XZR GLY A -5 UNP Q06124 EXPRESSION TAG SEQADV 5XZR SER A -4 UNP Q06124 EXPRESSION TAG SEQADV 5XZR HIS A -3 UNP Q06124 EXPRESSION TAG SEQADV 5XZR MET A -2 UNP Q06124 EXPRESSION TAG SEQADV 5XZR ALA A -1 UNP Q06124 EXPRESSION TAG SEQADV 5XZR SER A 0 UNP Q06124 EXPRESSION TAG SEQADV 5XZR ALA A 76 UNP Q06124 GLU 76 ENGINEERED MUTATION SEQRES 1 A 557 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 557 LEU VAL PRO ARG GLY SER HIS MET ALA SER MET THR SER SEQRES 3 A 557 ARG ARG TRP PHE HIS PRO ASN ILE THR GLY VAL GLU ALA SEQRES 4 A 557 GLU ASN LEU LEU LEU THR ARG GLY VAL ASP GLY SER PHE SEQRES 5 A 557 LEU ALA ARG PRO SER LYS SER ASN PRO GLY ASP PHE THR SEQRES 6 A 557 LEU SER VAL ARG ARG ASN GLY ALA VAL THR HIS ILE LYS SEQRES 7 A 557 ILE GLN ASN THR GLY ASP TYR TYR ASP LEU TYR GLY GLY SEQRES 8 A 557 GLU LYS PHE ALA THR LEU ALA ALA LEU VAL GLN TYR TYR SEQRES 9 A 557 MET GLU HIS HIS GLY GLN LEU LYS GLU LYS ASN GLY ASP SEQRES 10 A 557 VAL ILE GLU LEU LYS TYR PRO LEU ASN CYS ALA ASP PRO SEQRES 11 A 557 THR SER GLU ARG TRP PHE HIS GLY HIS LEU SER GLY LYS SEQRES 12 A 557 GLU ALA GLU LYS LEU LEU THR GLU LYS GLY LYS HIS GLY SEQRES 13 A 557 SER PHE LEU VAL ARG GLU SER GLN SER HIS PRO GLY ASP SEQRES 14 A 557 PHE VAL LEU SER VAL ARG THR GLY ASP ASP LYS GLY GLU SEQRES 15 A 557 SER ASN ASP GLY LYS SER LYS VAL THR HIS VAL MET ILE SEQRES 16 A 557 ARG CYS GLN GLU LEU LYS TYR ASP VAL GLY GLY GLY GLU SEQRES 17 A 557 ARG PHE ASP SER LEU THR ASP LEU VAL GLU HIS TYR LYS SEQRES 18 A 557 LYS ASN PRO MET VAL GLU THR LEU GLY THR VAL LEU GLN SEQRES 19 A 557 LEU LYS GLN PRO LEU ASN THR THR ARG ILE ASN ALA ALA SEQRES 20 A 557 GLU ILE GLU SER ARG VAL ARG GLU LEU SER LYS LEU ALA SEQRES 21 A 557 GLU THR THR ASP LYS VAL LYS GLN GLY PHE TRP GLU GLU SEQRES 22 A 557 PHE GLU THR LEU GLN GLN GLN GLU CYS LYS LEU LEU TYR SEQRES 23 A 557 SER ARG LYS GLU GLY GLN ARG GLN GLU ASN LYS ASN LYS SEQRES 24 A 557 ASN ARG TYR LYS ASN ILE LEU PRO PHE ASP HIS THR ARG SEQRES 25 A 557 VAL VAL LEU HIS ASP GLY ASP PRO ASN GLU PRO VAL SER SEQRES 26 A 557 ASP TYR ILE ASN ALA ASN ILE ILE MET PRO GLU PHE GLU SEQRES 27 A 557 THR LYS CYS ASN ASN SER LYS PRO LYS LYS SER TYR ILE SEQRES 28 A 557 ALA THR GLN GLY CYS LEU GLN ASN THR VAL ASN ASP PHE SEQRES 29 A 557 TRP ARG MET VAL PHE GLN GLU ASN SER ARG VAL ILE VAL SEQRES 30 A 557 MET THR THR LYS GLU VAL GLU ARG GLY LYS SER LYS CYS SEQRES 31 A 557 VAL LYS TYR TRP PRO ASP GLU TYR ALA LEU LYS GLU TYR SEQRES 32 A 557 GLY VAL MET ARG VAL ARG ASN VAL LYS GLU SER ALA ALA SEQRES 33 A 557 HIS ASP TYR THR LEU ARG GLU LEU LYS LEU SER LYS VAL SEQRES 34 A 557 GLY GLN GLY ASN THR GLU ARG THR VAL TRP GLN TYR HIS SEQRES 35 A 557 PHE ARG THR TRP PRO ASP HIS GLY VAL PRO SER ASP PRO SEQRES 36 A 557 GLY GLY VAL LEU ASP PHE LEU GLU GLU VAL HIS HIS LYS SEQRES 37 A 557 GLN GLU SER ILE MET ASP ALA GLY PRO VAL VAL VAL HIS SEQRES 38 A 557 CYS SER ALA GLY ILE GLY ARG THR GLY THR PHE ILE VAL SEQRES 39 A 557 ILE ASP ILE LEU ILE ASP ILE ILE ARG GLU LYS GLY VAL SEQRES 40 A 557 ASP CYS ASP ILE ASP VAL PRO LYS THR ILE GLN MET VAL SEQRES 41 A 557 ARG SER GLN ARG SER GLY MET VAL GLN THR GLU ALA GLN SEQRES 42 A 557 TYR ARG PHE ILE TYR MET ALA VAL GLN HIS TYR ILE GLU SEQRES 43 A 557 THR LEU GLN ARG ARG ILE GLU GLU GLU GLN LYS HET 8J6 A 601 28 HETNAM 8J6 4-(3-PHENYLPHENYL)-N-(2,2,6,6-TETRAMETHYLPIPERIDIN-4- HETNAM 2 8J6 YL)-1,3-THIAZOL-2-AMINE FORMUL 2 8J6 C24 H29 N3 S FORMUL 3 HOH *2(H2 O) HELIX 1 AA1 THR A 12 GLY A 24 1 13 HELIX 2 AA2 THR A 73 HIS A 84 1 12 HELIX 3 AA3 SER A 118 LYS A 129 1 12 HELIX 4 AA4 SER A 189 ASN A 200 1 12 HELIX 5 AA5 GLU A 225 LEU A 233 1 9 HELIX 6 AA6 GLN A 245 GLN A 256 1 12 HELIX 7 AA7 GLN A 257 LEU A 262 5 6 HELIX 8 AA8 ARG A 265 GLN A 269 5 5 HELIX 9 AA9 ASN A 273 ASN A 277 5 5 HELIX 10 AB1 LEU A 334 ASN A 336 5 3 HELIX 11 AB2 THR A 337 GLU A 348 1 12 HELIX 12 AB3 PRO A 432 SER A 448 1 17 HELIX 13 AB4 GLY A 464 GLY A 483 1 20 HELIX 14 AB5 ASP A 489 SER A 499 1 11 HELIX 15 AB6 THR A 507 GLU A 532 1 26 SHEET 1 AA1 6 LYS A 70 PHE A 71 0 SHEET 2 AA1 6 TYR A 63 LEU A 65 -1 N TYR A 63 O PHE A 71 SHEET 3 AA1 6 ALA A 50 GLN A 57 -1 N GLN A 57 O ASP A 64 SHEET 4 AA1 6 PHE A 41 ARG A 47 -1 N PHE A 41 O ILE A 56 SHEET 5 AA1 6 SER A 28 PRO A 33 -1 N SER A 28 O ARG A 46 SHEET 6 AA1 6 TYR A 100 PRO A 101 1 O TYR A 100 N PHE A 29 SHEET 1 AA2 4 PHE A 135 GLU A 139 0 SHEET 2 AA2 4 PHE A 147 THR A 153 -1 O SER A 150 N LEU A 136 SHEET 3 AA2 4 LYS A 166 GLN A 175 -1 O LYS A 166 N THR A 153 SHEET 4 AA2 4 LYS A 178 ASP A 180 -1 O LYS A 178 N GLN A 175 SHEET 1 AA3 2 MET A 202 GLU A 204 0 SHEET 2 AA3 2 THR A 208 LEU A 210 -1 O LEU A 210 N MET A 202 SHEET 1 AA4 2 ILE A 221 ASN A 222 0 SHEET 2 AA4 2 ASP A 487 ILE A 488 -1 O ILE A 488 N ILE A 221 SHEET 1 AA5 8 ALA A 307 ILE A 310 0 SHEET 2 AA5 8 TYR A 327 THR A 330 -1 O TYR A 327 N ILE A 310 SHEET 3 AA5 8 VAL A 455 HIS A 458 1 O VAL A 457 N ILE A 328 SHEET 4 AA5 8 VAL A 352 MET A 355 1 N VAL A 354 O VAL A 456 SHEET 5 AA5 8 ARG A 413 PHE A 420 1 O TYR A 418 N ILE A 353 SHEET 6 AA5 8 TYR A 396 LYS A 405 -1 N LEU A 401 O VAL A 415 SHEET 7 AA5 8 MET A 383 SER A 391 -1 N ARG A 384 O SER A 404 SHEET 8 AA5 8 LEU A 377 TYR A 380 -1 N LYS A 378 O VAL A 385 SHEET 1 AA6 2 VAL A 360 GLU A 361 0 SHEET 2 AA6 2 LYS A 364 SER A 365 -1 O LYS A 364 N GLU A 361 CISPEP 1 THR A 2 SER A 3 0 -17.85 CISPEP 2 LYS A 91 ASN A 92 0 11.35 CISPEP 3 VAL A 243 LYS A 244 0 -8.94 CISPEP 4 PRO A 297 ASN A 298 0 -3.91 CISPEP 5 GLU A 299 PRO A 300 0 -5.85 SITE 1 AC1 13 THR A 108 GLU A 110 ARG A 111 PHE A 113 SITE 2 AC1 13 ASN A 217 THR A 218 THR A 219 GLU A 249 SITE 3 AC1 13 GLU A 250 THR A 253 LEU A 254 PRO A 491 SITE 4 AC1 13 LYS A 492 CRYST1 41.280 55.750 219.190 90.00 90.00 90.00 P 2 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024225 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017937 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004562 0.00000